Merck & Co Inc

NYSE: MRK
$99.45
+$0.08 (+0.1%)
Closing Price on December 24, 2024

MRK Articles

The top analyst upgrades, downgrades and initiations seen on Wednesday included Arconic, Boston Beer, Dunkin' Brands, DuPont, GreenSky, International Flavors & Fragrances, Merck and Walt Disney.
Merck released better than expected second-quarter financial results before the markets opened on Tuesday.
Pfizer and Merck are each scheduled to release their second-quarter financial results early Tuesday. These are just a couple of the Dow Jones industrials that are reporting this week, but they make...
Seven of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week, including Apple, Exxon and Pfizer.
The July 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
24/7 Wall St. screened the Merrill Lynch US 1 list looking for the stocks paying the highest dividends, as rates are going nowhere this year or next, and the total return component of dividend-paying...
The June 28 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were increased.
President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the effort being blocked on free speech concerns.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Barrick Gold, CannTrust, Foot Locker, Inogen, L3Harris, Merck, Petrobras, Starbucks, Symantec and Tesla.
The June 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Top stock stories for the week of June 14, 2019 from earnings, mergers, analyst calls and more.
Merck is set to host its Investor Day on June 20. Investors will have a high bar of expectations because so much of Merck's story is known.
The May 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The top analyst upgrades, downgrades and initiations seen on Monday included Alarm.com, Exxon Mobil, Goldman Sachs BDC, Merck, Pinterest, Shopify, Wendy's and Zoom Video Communications.